Additional file 1: Table S1. of Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study Hisashi Yamanaka Yoshiya Tanaka Tsutomu Takeuchi Naonobu Sugiyama Hirotoshi Yuasa Shigeyuki Toyoizumi Yosuke Morishima Tomohiro Hirose Samuel Zwillich 10.6084/m9.figshare.c.3615428_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Tofacitinib_an_oral_Janus_kinase_inhibitor_as_monotherapy_or_with_background_methotrexate_in_Japanese_patients_with_rheumatoid_arthritis_an_open-label_long-term_extension_study/4376375 Summary of seven patient deaths. (PDF 14 kb) 2016-01-28 05:00:00 Tofacitinib Japanese Rheumatoid arthritis Long-term extension